FDA Clears T2 Biosystems’ Key Update in Sepsis Battle

T2 Biosystems Receives FDA Clearance to Update T2Bacteria Panel

T2 Biosystems has announced that it has received FDA clearance to update its T2Bacteria Panel, a test that detects sepsis-causing pathogens. The update includes the detection of a bacterium called Acinetobacter baumannii (A. baumannii), which is known for causing serious bloodstream infections with a high mortality rate in intensive care units. With this addition, the panel now covers approximately 75% of bacterial pathogens found in bloodstream infections leading to sepsis.